
Maryam Monshipouri
Examiner (ID: 849)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1653, 1652, 1656, 1651 |
| Total Applications | 2170 |
| Issued Applications | 1561 |
| Pending Applications | 225 |
| Abandoned Applications | 434 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18019072
[patent_doc_number] => 20220370571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/699927
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699927 | Augmented acid alpha-glucosidase for the treatment of Pompe disease | Mar 20, 2022 | Issued |
Array
(
[id] => 17853129
[patent_doc_number] => 20220283171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/700145
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700145 | METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES | Mar 20, 2022 | Pending |
Array
(
[id] => 19311774
[patent_doc_number] => 12037577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => DPO4 polymerase variants
[patent_app_type] => utility
[patent_app_number] => 17/653441
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15943
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653441 | DPO4 polymerase variants | Mar 2, 2022 | Issued |
Array
(
[id] => 19113159
[patent_doc_number] => 20240124909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITION AND METHOD FOR PRODUCTION OF FRUCTOSE
[patent_app_type] => utility
[patent_app_number] => 18/277380
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277380 | COMPOSITION AND METHOD FOR PRODUCTION OF FRUCTOSE | Feb 27, 2022 | Pending |
Array
(
[id] => 20279778
[patent_doc_number] => 20250305020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => Silk Gland Recombinant Expression Vector of Silkworm (Bombyx Mori) Expressing Human Epidermal Growth Factor, Preparation Method and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/280067
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280067 | Silk Gland Recombinant Expression Vector of Silkworm (Bombyx Mori) Expressing Human Epidermal Growth Factor, Preparation Method and Use Thereof | Feb 22, 2022 | Pending |
Array
(
[id] => 17687713
[patent_doc_number] => 20220195005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => INSULIN DERIVATIVES WITH A TERMINAL LPXT MOTIF
[patent_app_type] => utility
[patent_app_number] => 17/677670
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677670 | INSULIN DERIVATIVES WITH A TERMINAL LPXT MOTIF | Feb 21, 2022 | Abandoned |
Array
(
[id] => 17998036
[patent_doc_number] => 11499132
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-15
[patent_title] => Membrane bioreactor for simultaneous enzymatic cellulose hydrolysis and product separation
[patent_app_type] => utility
[patent_app_number] => 17/676099
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 6982
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676099 | Membrane bioreactor for simultaneous enzymatic cellulose hydrolysis and product separation | Feb 17, 2022 | Issued |
Array
(
[id] => 18575770
[patent_doc_number] => 11732286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => T5 exonuclease-based method to identify DNA topoisomerase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/670738
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 36
[patent_no_of_words] => 9776
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670738 | T5 exonuclease-based method to identify DNA topoisomerase inhibitors | Feb 13, 2022 | Issued |
Array
(
[id] => 19098103
[patent_doc_number] => 20240117331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => POLYPEPTIDES HAVING PECTINASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/262864
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 174353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262864 | POLYPEPTIDES HAVING PECTINASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME, AND USES THEREOF | Feb 6, 2022 | Pending |
Array
(
[id] => 19098103
[patent_doc_number] => 20240117331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => POLYPEPTIDES HAVING PECTINASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/262864
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 174353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262864 | POLYPEPTIDES HAVING PECTINASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME, AND USES THEREOF | Feb 6, 2022 | Pending |
Array
(
[id] => 17776838
[patent_doc_number] => 20220243187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
[patent_app_type] => utility
[patent_app_number] => 17/665265
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665265 | ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME | Feb 3, 2022 | Abandoned |
Array
(
[id] => 17807740
[patent_doc_number] => 20220259575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => POLYPEPTIDE HAVING LUCIFERASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/550495
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550495 | Polypeptide having luciferase activity | Dec 13, 2021 | Issued |
Array
(
[id] => 17704945
[patent_doc_number] => 20220204951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ENGINEERED GLUCOSYLTRANSFERASES
[patent_app_type] => utility
[patent_app_number] => 17/548677
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548677
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548677 | ENGINEERED GLUCOSYLTRANSFERASES | Dec 12, 2021 | Abandoned |
Array
(
[id] => 19326187
[patent_doc_number] => 12043854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Processes for reducing steam consumption and improving process carbon balance in biomass conversion to sugars, biochemicals, biofuels, and/or biomaterials
[patent_app_type] => utility
[patent_app_number] => 18/018303
[patent_app_country] => US
[patent_app_date] => 2021-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 43087
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018303 | Processes for reducing steam consumption and improving process carbon balance in biomass conversion to sugars, biochemicals, biofuels, and/or biomaterials | Dec 10, 2021 | Issued |
Array
(
[id] => 19572215
[patent_doc_number] => 20240376507
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-11-14
[patent_title] => CELLULOLYTIC ENZYME COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/547836
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547836 | Cellulolytic enzyme compositions and uses thereof | Dec 9, 2021 | Issued |
Array
(
[id] => 19572215
[patent_doc_number] => 20240376507
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-11-14
[patent_title] => CELLULOLYTIC ENZYME COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/547836
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547836 | Cellulolytic enzyme compositions and uses thereof | Dec 9, 2021 | Issued |
Array
(
[id] => 17482472
[patent_doc_number] => 20220089976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => CLEANING COMPOSITIONS COMPRISING AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/546094
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546094 | CLEANING COMPOSITIONS COMPRISING AMYLASE VARIANTS | Dec 8, 2021 | Pending |
Array
(
[id] => 17482472
[patent_doc_number] => 20220089976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => CLEANING COMPOSITIONS COMPRISING AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/546094
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546094 | CLEANING COMPOSITIONS COMPRISING AMYLASE VARIANTS | Dec 8, 2021 | Pending |
Array
(
[id] => 19020535
[patent_doc_number] => 20240076706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => 1,3/1,4-XYLANASE MLX1034, ITS GENE AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/261847
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261847 | 1,3/1,4-XYLANASE MLX1034, ITS GENE AND APPLICATIONS THEREOF | Dec 6, 2021 | Pending |
Array
(
[id] => 19763360
[patent_doc_number] => 12221639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Allulose epimerase variant with excellent thermal stability, preparation method therefor, and preparation method for allulose using same
[patent_app_type] => utility
[patent_app_number] => 18/267874
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6991
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267874
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267874 | Allulose epimerase variant with excellent thermal stability, preparation method therefor, and preparation method for allulose using same | Nov 21, 2021 | Issued |